SCHEMBL12366162

SCHEMBL12366162

[C-]#[N+]CC(=O)NCc1ccc(Cl)cc1C

nearest known ligand 0.54

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
P2RX7 Q99572 9/20 0.54
HDAC3 O15379 1/20 0.45
HDAC1 Q13547 1/20 0.45
HDAC2 Q92769 1/20 0.45
HDAC6 Q9UBN7 1/20 0.45
ERCC1 P07992 3/20 0.45
ERCC4 Q92889 3/20 0.45
ANO1 Q5XXA6 1/20 0.44
ANO2 Q9NQ90 1/20 0.44
ALDH1A1 P00352 1/20 0.43
TDP1 Q9NUW8 1/20 0.41
NPC1 O15118 2/20 0.41
RAB9A P51151 2/20 0.41
CYP1A2 P05177 1/20 0.41
CYP3A4 P08684 1/20 0.41
CYP2D6 P10635 1/20 0.41
CYP2C9 P11712 1/20 0.41
CYP2C19 P33261 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12366130 0.85 NPC1 (0.56) P2RX7ALDH1A1NPC1RAB9ASMN1; SMN2
SCHEMBL12366171 0.85 ALDH1A1 (0.58) P2RX7ERCC1ERCC4ALDH1A1NPC1
SCHEMBL23565221 0.82 P2RX7 (0.59) P2RX7HDAC3HDAC1HDAC2HDAC6
SCHEMBL3130070 0.80 P2RX7 (0.56) P2RX7HDAC3HDAC1HDAC2HDAC6
SCHEMBL12366090 0.79 ALDH1A1 (0.57) P2RX7ALDH1A1NPC1RAB9ASMN1; SMN2
SCHEMBL9926539 0.79 SETDB1 (0.57) P2RX7HDAC3HDAC1HDAC2HDAC6
SCHEMBL2266083 0.77 P2RX7 (0.54) P2RX7HDAC3HDAC1HDAC2HDAC6
SCHEMBL12366175 0.77 NPC1 (0.56) P2RX7ALDH1A1NPC1RAB9ASMN1; SMN2
SCHEMBL12366142 0.75 KMT2A (0.59) ERCC1ERCC4ALDH1A1TDP1NPC1
SCHEMBL15682778 0.75 HDAC1 (0.54) P2RX7HDAC3HDAC1HDAC2HDAC6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7998986-B2 Heterocyclic compounds, in particular N-substituted pyridones for modulating the activity of nuclear receptors EXELIXIS PATENT COMPANY LLC (US) 2011-08-16 US disclosed